Progress often happens in slow trickles. And in the movement toward LGBTQ+ equality, small political advances over decades have led to a larger cultural shift. In just the last 10 years, same-sex ...

Companies including GSK, Merck, Roche and Sanofi are pushing new approaches in cancer and inflammatory diseases.

The Danish biotech sharpened its global vaccine ambitions by tapping Tarja Stenvall, a Big Pharma vet, to take the helm.

Roche announced it's building autonomous AI-powered labs; how a clinical hold on an epilepsy trial could impact Biohaven ...

The error points to a big question for pharma as AI gains autonomy and high-profile failures sharpen safety concerns: What ...

Nimbus Therapeutics’ head of R&D dishes on what’s next in AI-enabled drug discovery, years after Takeda completed its ...

Basecamp Research just netted $140 million in a series C fundraising round that valued the company at $800 million, according ...

Patients in psychedelic trials often know if they’re taking the study drug or a placebo. But trial design changes could ...

Major oncology pharmas employ different strategies when building their pipelines, but one recent common factor among Big Pharma is a bet on antibody-drug conjugates that many see as replacements for ...

Genetic medicines and more selective small molecules are finally pushing the field toward new mechanisms — and potentially ...